According to settlements reached with the Department of Justice, at least six major healthcare facilities have agreed to stop providing gender‑affirming surgery and hormone treatments to young transgender patients. In exchange, the institutions will remit funds to the federal government from patients seeking to reverse transition procedures. The most recent agreements were finalized last week, following earlier commitments by hospitals that had already halted such care under state bans or earlier pressure from the Trump administration.
The agreements end active DOJ investigations into past care and prevent hospitals from being compelled to surrender patient records. Justice officials noted that some providers have pledged financial assistance for the medical costs of youth who wish to detransition. While the hospitals have not admitted wrongdoing, the settlements include payments such as $8.5 million from New York University Langone Hospitals and $950,000 from the University of Pittsburgh Medical Centers. Similar pacts were reached with the Cleveland Clinic, Connecticut Children’s Hospital, Mount Sinai Health System, and Texas Children’s Hospital.
Despite these changes, hospital officials said the agreements would not affect their pediatric mental‑health programs that support transgender children. The settlements came after a federal review in 2025 that urged limiting youth care to therapy, a stance opposed by major medical groups such as the American Medical Association and the American Academy of Pediatrics.
Legal challenges continue, with an appeals court ruling that the DOJ’s pursuit of ending pediatric gender‑affirming care is a legitimate administrative objective. Meanwhile, families have sometimes relocated to other states or abroad to seek care, only to find providers in those locations also halting treatment. The situation highlights ongoing tensions between federal policy, state laws, and medical practice regarding transgender youth care.
.jpg?trim=1,0,1,0&width=1200&height=800&crop=1200:800)
